Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749437 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
A Phase 1 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT00749437 is a Phase 1 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 34 participants.
The verdict
NCT00749437, a Phase 1 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Placing gold markers in the area where the tumor was removed may help doctors better direct radiation therapy and help reduce the risk of cancer recurrence. PURPOSE: This phase I trial is studying how well radiation therapy using gold markers works in treating women with early-stage breast cancer.
Interventions
- RADIATION 3-dimensional conformal accelerated partial breast irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749437
The ClinicalTrials.gov registry entry for NCT00749437 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 3-dimensional conformal accelerated partial breast irradiation is the first listed.
NCT00749437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749437 about?
NCT00749437 is a clinical study titled "Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Placing gold markers in the area where the tumor was removed may help doctors better direct radiation therapy and help reduce the risk of cancer recurrence. PURPOSE: This phase I trial is studying how well radiation therapy u...
What is the current status of trial NCT00749437?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2008-10. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00749437?
The interventions under investigation include: 3-dimensional conformal accelerated partial breast irradiation (RADIATION).
Who is sponsoring clinical trial NCT00749437?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.